Skip to content
The Policy VaultThe Policy Vault

Venclexta (venetoclax) — Medica

Acute Myeloid Leukemia (includes Blastic Plasmacytoid Dendritic Cell Neoplasm)

Initial criteria

  • age ≥ 18 years
  • used in combination with azacitidine OR decitabine OR cytarabine

Approval duration

1 year